Prospective Registry of Percutaneous Transluminal Angioplasty for Intracranial Atheroslerotic Disease

Prospective Registry of Percutaneous Transluminal Angioplasty for Intracranial Atheroslerotic Disease - AICAD

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017070

Enrollment

300

Registered

2015-04-10

Start date

2016-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Atheroslerotic Disease

Interventions

Percutaneous transluminal angioplasty and stenting for intracranial atheroslerotic disease

Sponsors

Kobe City Medical Center General Hospital

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 intracranial atheroslcerotic disease 2 possible to treat with percutaneous transluminal angioplasty and stenting 3 no other effective medical management 4 without using Wingspan

Exclusion criteria

Exclusion criteria: no limitation

Design outcomes

Primary

Measure	Time frame
any death within 30days and ipsilateral stroke from 31 days to 1 year	—

Secondary

Measure	Time frame
1. any death and neurological death within 72 hours and 30 days 2. any stroke, hemorrhagic stroke, ischemic stroke and ipsilateral stroke within 72 hours and 30 days 3. recover of stroke within 3 months 4. restenosis of target lesion within 1 year 5. re-treatment of target lesion within 1 year 6. symptomatic stroke dueto restenosis of target lesion within 1 year 7. any adverse event	—

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center General Hospital Neurosurgery

n.sakai@siren.ocn.ne.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026